Can Brainwaves Become Biomarkers?

In this special episode of unNatural Selection, produced in partnership with Mass General Brigham ahead of the World Medical Innovation Forum, we explore how AI is transforming EEG from a blunt clinical tool into a precision instrument for neuroscience.

We dive into how companies like Beacon Biosignals are decoding brainwaves at scale—advancing drug development, redefining diagnostics, and opening new frontiers in neurological care.

It’s a conversation about data, pattern recognition, and the race to make sense of the brain’s most elusive signals.